Human antibodies for the generation of new red blood cell antigen typing reagents.

Human antibodies for the generation of new red blood cell antigen typing reagents. - Development of recombinant antibodies

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50548

Enrollment

Registered

2020-02-05

Start date

2020-06-30

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patienten met antistoffen gericht tegen rode bloedcel antigenen alloimmunization Blood transfusion

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients (at least 18 years of age) who formed antibodies against RBC antigens. The specificity of these antibodies have been determined by Sanquin Immunohaematology Diagnostics.

Exclusion criteria

Exclusion criteria: Patients below the age of 18, incapacitated patients and patients who cannot understand the information

Design outcomes

Primary

Measure	Time frame
Monoclonal antibodies generated with recombinant-DNA technology from antibody producing B-cells from patients with RBC antibodies.	—

Countries

Netherlands

Outcome results